ICRU REPORT 96, Dosimetry-Guided Radiopharmaceutical Therapy

剂量学 医学物理学 放射生物学 医学 放射治疗计划 核医学 放射治疗 外科
作者
George Sgouros,Wesley Emmett Bolch,Arturo Chiti,Yuni K. Dewaraja,Dimitris Emfietzoglou,Robert F. Hobbs,Mark Konijnenberg,Katarina Sjögreen Gleisner,Lidia Strigari,Tzu‐Chen Yen,Roger W. Howell
出处
期刊:Journal of the International Commission on Radiation Units and Measurements [SAGE Publishing]
卷期号:21 (1): 1-212 被引量:165
标识
DOI:10.1177/14736691211060117
摘要

Radiopharmaceutical therapy (RPT) is a radiation delivery modality that uses radionuclides to irradiate tissues with various forms of ionizing radiation. In most forms of RPT, the radionuclide is targeted to the diseased tissue following systemic administration of the pharmaceutical that circulates throughout the body and delivers radiation to sites of radiopharmaceutical accumulation. Three major classes of radionuclides are used in RPT including beta-particle emitters, alpha-particle emitters, and Auger-electron emitters. Recent therapeutic successes and regulatory approval of some commercial radiopharmaceuticals have spurred development of new agents. Unfortunately, comparisons of clinical results and optimization of RPT are hindered by the absence of standardized practices for prescribing, reporting, and recording of dosimetric quantities related to RPT. The present report provides information necessary to standardize techniques and procedures and to harmonize the clinical prescription, recording, and reporting of dosimetry for RPT in a manner that facilitates the use of RPT alone or in combination with other modalities. The Report's introduction briefly outlines the rationale and historical development of RPT. Then fundamental concepts of radionuclides and radiation dosimetry are reviewed. This is followed by a description of the radiobiology of RPT as compared with external photon radiation, along with bioeffect models used to calculate relative biological effectiveness (RBE) and equieffective dose for treatment planning. The cornerstone of the report comprises key concepts and terminology needed to implement dosimetry and treatment planning for RPT. These definitions are used in the recommended absorbed dose prescriptions. Essential to this end are reproducible procedures for quantifying activity in the various source regions. Accordingly, an extensive set of recommendations for activity quantification are described within, along with how to acquire and use pharmacokinetic data to obtain the time integrated activity in source regions. This is followed by methods to calculate the absorbed dose to the dosimetric treatment regions and regions at risk (RARs). The implementation of absorbed dose in RPT treatment planning, and in combination therapies, is then addressed. Subsequent sections describe recommendations for prescribing, recording, and reporting treatments. The report ends with four clinical examples of RPT for different tumor entities to illustrate the application of the recommendations. Specific recommendations in this report include the use of the quantity equieffective dose (EQDX) in units of gray (Gy) which accounts for the dependence of radiobiological responses on absorbed dose rate, fractionation, and linear energy transfer (LET). To avoid confusion, both absorbed dose and equieffective dose should be specified. A new quantity, the standardized relative biological effectiveness (sRBEX), is defined to facilitate bioeffect modeling for high LET radiations such as alpha particles and Auger electrons. In addition, new ICRU definitions of regions and geometric concepts to be used in RPT include localization regions, source regions, clinical treatment regions, dosimetric treatment regions, and RARs; reflecting a unique aspect of RPT relative to radiotherapy, these regions may be delineable or nondelineable. Finally, analogous to external beam radiation therapy, specific recommendations for ICRU reporting levels for RPT are recommended which are specific to each radiopharmaceutical. The Report should be an important and useful reference for all practitioners in RPT and should facilitate comparisons of clinical results from different centers. The focus of dosimetry-guided RPT makes explicit the potential of RPT to target and control tumors while reducing normal tissue toxicity. For all new users and interested readers, the description of the basic concepts and background of RPT should enable them to understand the techniques involved in RPT.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Ava的应助被Jay采纳,获得10
1秒前
心静发布了新的文献求助10
1秒前
1秒前
1秒前
研友_VZG7GZ的应助被张博采纳,获得10
1秒前
淡然以蓝发布了新的文献求助10
2秒前
2秒前
王云豆完成签到,获得积分10
2秒前
FashionBoy的应助被慕木采纳,获得10
2秒前
3秒前
小金发布了新的文献求助10
3秒前
3秒前
龙弟弟发布了新的文献求助10
4秒前
4秒前
4秒前
李健的粉丝团团长的应助被cgh采纳,获得10
5秒前
NexusExplorer的应助被yami采纳,获得10
5秒前
赘婿的应助被渣渣XM采纳,获得100
5秒前
5秒前
路路完成签到,获得积分10
5秒前
Owen的应助被侯小遥采纳,获得10
5秒前
5秒前
6秒前
6秒前
DDACCZ完成签到,获得积分10
6秒前
汉堡包的应助被以州采纳,获得10
6秒前
6秒前
鸡血红发布了新的文献求助10
6秒前
nwds发布了新的文献求助10
6秒前
baobao发布了新的文献求助10
7秒前
Owen的应助被Dale采纳,获得10
7秒前
李健的应助被Dale采纳,获得10
7秒前
在水一方的应助被lily采纳,获得10
7秒前
7秒前
花花衬衫发布了新的文献求助10
7秒前
牛牛牛完成签到,获得积分10
7秒前
李健的粉丝团团长的应助被lkk采纳,获得10
8秒前
8秒前
jc哥完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181014
求助须知:如何正确求助?哪些是违规求助? 9571039
关于积分的说明 21816042
捐赠科研通 7777369
什么是DOI,文献DOI怎么找? 3433378
关于科研通互助平台的介绍 2557621
邀请新用户注册赠送积分活动 2479385